These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6727439)

  • 1. Influence of age-related changes in rodent liver morphology and physiology on drug metabolism--a review.
    van Bezooijen CF
    Mech Ageing Dev; 1984; 25(1-2):1-22. PubMed ID: 6727439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in hepatic microsomal drug metabolism are substrate selective.
    Rikans LE; Notley BA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):574-8. PubMed ID: 7062268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of liver congestion on hepatic drug metabolism in the rat.
    Knodell RG; Farleigh RM; Steele NM; Bond JH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age- and gender-related variations in the activities of drug-metabolizing and antioxidant enzymes in the white-footed mouse (Peromyscus leucopus).
    Guo Z; Wang M; Tian G; Burger J; Gochfeld M; Yang CS
    Growth Dev Aging; 1993; 57(2):85-100. PubMed ID: 8495997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
    Spaethe SM; Jollow DJ
    Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
    Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
    Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
    Feuer G
    Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
    de Waziers I; Boisset M; Atteba S
    Drug Metab Dispos; 1988; 16(2):310-5. PubMed ID: 2898352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic drug metabolism in rats with experimental chronic renal failure.
    Patterson SE; Cohn VH
    Biochem Pharmacol; 1984 Mar; 33(5):711-6. PubMed ID: 6424678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dimethylformamide on hepatic microsomal monooxygenase system and glutathione metabolism in rats.
    Imazu K; Fujishiro K; Inoue N
    Toxicology; 1992; 72(1):41-50. PubMed ID: 1539172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic drug metabolism during development in food-restricted female Sprague-Dawley rats.
    Lemay J; Audet M; Yousef IM; Tuchweber B
    Mech Ageing Dev; 1991 Sep; 60(1):75-87. PubMed ID: 1745066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered enzyme activities of xenobiotic biotransformation in kidneys after subchronic administration of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) to rats.
    Heiskanen K; Linström-Seppä P; Haataja L; Vaittinen SL; Vartiainen T; Komulainen H
    Toxicology; 1995 Jun; 100(1-3):121-8. PubMed ID: 7624869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-metabolizing enzymes: mechanisms and functions.
    Sheweita SA
    Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism under pathological and abnormal physiological states in animals and man.
    Kato R
    Xenobiotica; 1977; 7(1-2):25-92. PubMed ID: 322397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.